Article

Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a cohort study

2022-01-23

Abstract excerpt

<h4>Summary</h4> <h4>Background</h4> The SARS-CoV-2 pandemic remains a worldwide challenge. The CRIT-Cov-U pilot study generated a urinary proteomic biomarker consisting of 50 peptides (COV50), which predicted death and disease progression. Following the interim analysis demanded by the German government, the full dataset was analysed to consolidate findings and propose clinical applications. <h4>Methods</h4> In e...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f79c7782-3fdd-56c5-9c2d-9b1532a311e8
DOI: 10.1101/2022.01.20.22269599

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a cohort studyDOI 10.1101/2022.01.20.22269599Read

Predictive Performance and Clinical Application of COV50, A Urinary Proteomic Biomarker in Early COVID-19 Infection: A Cohort StudySemantic proximity Read

Urinary peptides predict future deathSemantic proximity Read

Predicting COVID-19 Patients Outcome Trajectories Using Proteomics and Clinical Biosignatures: A Comprehensive Machine Learning and Bioinformatics ApproachSemantic proximity Read

International Comparisons of Harmonized Laboratory Value Trajectories to Predict Severe COVID-19: Leveraging the 4CE Collaborative Across 342 Hospitals and 6 Countries: A Retrospective Cohort StudySemantic proximity Read

Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19Semantic proximity Read

Diagnostic Performance of a Blood Urea Nitrogen to Creatinine Ratio-Based Nomogram for Predicting in-Hospital Mortality in COVID-19 PatientsSemantic proximity Read

SGLT2-Inhibition reverts urinary peptide changes associated with severe COVID-19: an<i>in-silico</i>proof-of-principle of proteomics-based drug repurposingSemantic proximity Read

Urinary collagen peptides predict mortalitySemantic proximity Read

Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of COVID-19.Semantic proximity Read

Clinical Study Protocol of the ‘Biomarkers of Severity of COVID-19 Patients’ (BIOMARCOVID) ProjectSemantic proximity Read

A circulating proteome-informed prognostic model of COVID-19 disease activity that relies on routinely available clinical laboratoriesSemantic proximity Read

Landscaping of Urine Proteome: Unlocking Diagnostic Potential and Overcoming Unique ChallengesSemantic proximity Read